As part of ATS 2025 the International Conference Committee will organize a high-profile Clinical Trials Symposium to feature new breakthroughs in treatment and management of adult and pediatric pulmonary, critical care, and sleep disorders. This session is a platform for important Phase III trial results but can also feature results from large Phase II trials that are novel and represent important new understandings.
Deadline: Wednesday, March 5
Revisit the key moments of ATS 2025. Access all the inspiring presentations, valuable clinical insights, and presentations from pulmonary, critical care, and sleep sessions with our ATS Conference Highlight packages. Check out our package options and pick the one that's right for you.
When you become a member of our global American Thoracic Society community of 16,000+ health care providers and researchers, you'll have access to:
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.
© 1998 - 2024 American Thoracic Society, all rights reserved.
American Thoracic Society
25 Broadway
New York, NY 10004
United States of America
Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: conferencequestions@thoracic.org
Privacy Statement | Term of Use | COI
Conference Code of Conduct